Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Howard

Showing results (651-660 of 876) with videos related to

Pageof 88
Sort By:
Blood Advances|May 5, 2019
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII productsWojciech Jankowski, Yara Park, Joseph McGill, et al.
Journal of Medical Genetics|June 17, 2003
Is the locus for Costello syndrome on 11p?B Kerr, M L Mucchielli, S Sigaudy, et al.
Cancer|April 30, 2019
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH databaseFarnoosh Nik-Ahd, Lauren E Howard, Adva T Eisenberg, et al.
Respiratory Care|April 19, 2023
A Multidisciplinary Approach to Verbal Communication Interventions for Mechanically Ventilated Adults With a TracheostomyCharissa J Zaga, Caroline Chao, Tanis Cameron, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Urology|November 16, 2005
Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcomeDaniel A Barocas, Hideki Kawamoto, David F Dreizin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 2018
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE TrialEmma H Allott, Sarah C Markt, Lauren E Howard, et al.
Clinical Pharmacology and Therapeutics|June 13, 2022
Calibration and Validation of a Mechanistic COVID-19 Model for Translational Quantitative Systems Pharmacology - A Proof-of-Concept Model Development for RemdesivirMohammadreza Samieegohar, James L Weaver, Kristina E Howard, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Pageof 88

Showing results (651-660 of 876) with videos related to

Sort By:
Pageof 88
Blood Advances|May 5, 2019
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII productsWojciech Jankowski, Yara Park, Joseph McGill, et al.
Journal of Medical Genetics|June 17, 2003
Is the locus for Costello syndrome on 11p?B Kerr, M L Mucchielli, S Sigaudy, et al.
Cancer|April 30, 2019
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH databaseFarnoosh Nik-Ahd, Lauren E Howard, Adva T Eisenberg, et al.
Respiratory Care|April 19, 2023
A Multidisciplinary Approach to Verbal Communication Interventions for Mechanically Ventilated Adults With a TracheostomyCharissa J Zaga, Caroline Chao, Tanis Cameron, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Urology|November 16, 2005
Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcomeDaniel A Barocas, Hideki Kawamoto, David F Dreizin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 2018
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE TrialEmma H Allott, Sarah C Markt, Lauren E Howard, et al.
Clinical Pharmacology and Therapeutics|June 13, 2022
Calibration and Validation of a Mechanistic COVID-19 Model for Translational Quantitative Systems Pharmacology - A Proof-of-Concept Model Development for RemdesivirMohammadreza Samieegohar, James L Weaver, Kristina E Howard, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Pageof 88